| Followers | 40 |
| Posts | 1956 |
| Boards Moderated | 0 |
| Alias Born | 03/24/2014 |
Wednesday, October 13, 2021 11:52:21 PM
At least your first entry point into NWBO doesn't date back to 2013.
Oh the timelines were fast and furious from LG back then.
Fast foward 8 years...not a single, not one timeline that LG or this Co has ever given has been on target. FFS, I have gone gray in the meantime
Silly me, kept buying the whole time from initial entry point just under $4 all the way up to $12 and then down to .14.
Thought I had it good with 15K shares at $12. Gonna be really good when TLD along with other news spikes this to $8-10 (hopefully) with 250K shares now.
If I were soley basing this investment on management I'd have left LONG ago. My bet is on Dr Liau along with others who give me confidence in spite of abismal management who I truly feel has completely mislead investors over the past 8yrs.
I'm thinking after this is all said and done LG should take his talents to a used car dealership...honestly!
Oh the timelines were fast and furious from LG back then.
Fast foward 8 years...not a single, not one timeline that LG or this Co has ever given has been on target. FFS, I have gone gray in the meantime
Silly me, kept buying the whole time from initial entry point just under $4 all the way up to $12 and then down to .14.
Thought I had it good with 15K shares at $12. Gonna be really good when TLD along with other news spikes this to $8-10 (hopefully) with 250K shares now.
If I were soley basing this investment on management I'd have left LONG ago. My bet is on Dr Liau along with others who give me confidence in spite of abismal management who I truly feel has completely mislead investors over the past 8yrs.
I'm thinking after this is all said and done LG should take his talents to a used car dealership...honestly!
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
